Norah Clinical Solution (India) Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 14-12-2024
- Paid Up Capital ₹ 4.80 M
as on 14-12-2024
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 1.05%
(FY 2022)
- Profit 64.20%
(FY 2022)
- Ebitda 60.82%
(FY 2022)
- Net Worth 9.58%
(FY 2022)
- Total Assets 17.73%
(FY 2022)
About Norah Clinical Solution (India)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.80 M, as per Ministry of Corporate Affairs (MCA) records.
Kalyan Chhotoroy, Amiya Prasad, and Alok Samantaray serve as directors at the Company.
- CIN/LLPIN
U72900OR2017PTC027069
- Company No.
027069
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 May 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Khorda, Odisha, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Norah Clinical Solution (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kalyan Chhotoroy  | Director | 02-Apr-2018 | Current |
| Amiya Prasad | Director | 19-May-2017 | Current |
| Alok Samantaray | Director | 19-May-2017 | Current |
Financial Performance and Corporate Structure Insights of Norah Clinical Solution (India).
Norah Clinical Solution (India) Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 1.05% increase. The company also saw a substantial improvement in profitability, with a 64.2% increase in profit. The company's net worth moved up by a moderate rise of 9.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Norah Clinical Solution (India)?
Unlock access to Norah Clinical Solution (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Ray Research & Consulting Private LimitedActive 13 years 1 day
Amiya Prasad and Alok Samantaray are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Norah Clinical Solution (India)?
Unlock and access historical data on people associated with Norah Clinical Solution (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Norah Clinical Solution (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Norah Clinical Solution (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
